$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of whether linezolid is an imported drug and its domestic marketing sources and channels
2026-02-01 22:25:32
Check Details
Whether ribociclib (Calilon) must be taken continuously for three years and the impact of long-term treatment on breast cancer patients
2026-02-01 22:25:32
Check Details
Cemiplimab was developed by which international pharmaceutical company and approved for use worldwide
2026-02-01 22:25:32
Check Details
A comprehensive analysis of the indications, usage, dosage and precautions in the official instructions of Daprodustat
2026-02-01 22:25:32
Check Details
Approximate cost of complete one-year treatment with durvalumab (durvalumab) and analysis of influencing factors
2026-02-01 22:25:32
Check Details
The latest market price of Zolbetuximab in 2026 and reference for drug purchase costs through different channels
2026-02-01 22:25:32
Check Details
Analysis of the main functions, side effects and clinical use precautions of EIKANCE 0.01% atropine sulfate eye drops
2026-02-01 22:25:32
Check Details
Explanation of overseas purchase channels and price of pacritinib
2026-02-01 22:25:32
Check Details
Analysis of the main functions of Letermovir (Premin) and its application in preventing infection after transplantation
2026-02-01 22:25:32
Check Details
Etrasimod tablets (Etrasimod)-Velsipity pharmacological mechanism and clinical application overview
2026-02-01 22:25:32
Check Details
Description of the risks, side effects and precautions for using Rutrombopag (Venda)
2026-02-01 22:25:32
Check Details
Analysis of Omarigliptin taking time selection and medication recommendations
2026-02-01 22:25:32
Check Details
1
2
...
2398
2399
2400
2401
2402
2403
2404
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
2
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
3
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
4
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
5
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
9
Adagrasib Medication Management Guide for Special Populations
10
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
11
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
12
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment